Eos-003

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEos-003
Drug Alias NameEos-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsTopoisomerase (DNA) II alpha inhibitors
TargetsDNATopoisomerase (DNA) II alpha
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbreos Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesAbreos Biosciences
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A